- Home
- BNS vs EW Comparison
BNS vs EW Comparison
Compare BNS & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNS
- EW
- Stock Information
- Founded
- BNS 1832
- EW 1958
- Country
- BNS Canada
- EW United States
- Employees
- BNS N/A
- EW N/A
- Industry
- BNS
- EW Industrial Specialties
- Sector
- BNS
- EW Health Care
- Exchange
- BNS Nasdaq
- EW Nasdaq
- Market Cap
- BNS 58.6B
- EW 41.3B
- IPO Year
- BNS N/A
- EW 2000
- Fundamental
- Price
- BNS $53.52
- EW $68.44
- Analyst Decision
- BNS Sell
- EW Buy
- Analyst Count
- BNS 1
- EW 22
- Target Price
- BNS $70.00
- EW $76.67
- AVG Volume (30 Days)
- BNS 2.0M
- EW 6.3M
- Earning Date
- BNS 11-26-2024
- EW 10-24-2024
- Dividend Yield
- BNS 5.87%
- EW N/A
- EPS Growth
- BNS N/A
- EW 7.71
- EPS
- BNS 4.14
- EW 2.43
- Revenue
- BNS $21,427,899,202.00
- EW $6,204,400,000.00
- Revenue This Year
- BNS N/A
- EW $6.33
- Revenue Next Year
- BNS $5.26
- EW $2.08
- P/E Ratio
- BNS $12.94
- EW $28.16
- Revenue Growth
- BNS 3.35
- EW 19.30
- 52 Week Low
- BNS $39.80
- EW $58.93
- 52 Week High
- BNS $55.12
- EW $96.12
- Technical
- Relative Strength Index (RSI)
- BNS 59.70
- EW 53.69
- Support Level
- BNS $52.18
- EW $67.65
- Resistance Level
- BNS $53.32
- EW $69.80
- Average True Range (ATR)
- BNS 0.57
- EW 1.55
- MACD
- BNS -0.16
- EW 0.40
- Stochastic Oscillator
- BNS 64.16
- EW 76.51
About BNS Bank Nova Scotia Halifax Pfd 3
Bank of Nova Scotia is a global financial services provider. The bank has five business segments: Canadian banking, international banking, global wealth management, global banking and markets, and other. It offers a range of advice, products, and services, including personal and commercial banking, wealth management and private banking, corporate and investment banking, and capital markets. The bank's international operations span numerous countries and are more concentrated in Central and South America.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.